Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct;36(5):257-265.
doi: 10.5021/ad.24.022.

Updates in Dermatomyositis: Newer Treatment Options and Outcome Measures From Dermatologic Perspectives

Hee Joo Kim  1 , Victoria P Werth  2   3
Affiliations
Review

Updates in Dermatomyositis: Newer Treatment Options and Outcome Measures From Dermatologic Perspectives

Hee Joo Kim et al. Ann Dermatol. 2024 Oct.

Abstract

Dermatomyositis (DM) is a rare autoimmune connective tissue disease with characteristic skin manifestations and possible muscle involvement. Recent advances in classification system to include skin-predominant subtypes, understanding underlying pathogenic mechanisms and the relationship between clinical phenotypes and myositis-specific autoantibodies have led to development of novel therapeutic options. This corresponds with efforts to develop better outcome measures to accurately catch the patients' current disease status and treatment-induced improvements. This report will review the updates in newer treatments and outcome measures of DM, specifically from a dermatologic point of view.

Keywords: Dermatomyositis; Outcome measures; Treatment.

PubMed Disclaimer

Conflict of interest statement

The authors have nothing to disclose.

Similar articles

See all similar articles

Cited by

References

    1. Jorizzo JL, Vleugels RA. In: Dermatology. 4th ed. Bolognia JL, Schaffer JV, Cerroni L, editors. Amsterdam: Elsevier; 2018. Dermatomyositis; pp. 681–692.
    1. Lewis M, Fiorentino D. In: Fitzpatrick's dermatology. 9th ed. Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, Mcmichael AJ, et al., editors. New York: McGraw-Hill Education; 2019. Chapter 62: dermatomyositis; pp. 1061–1085.
    1. Lim D, Fiorentino D, Werth V. Current concepts and advances in dermatomyositis: a dermatological perspective. Clin Exp Rheumatol. 2023;41:359–369. - PubMed
    1. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts) N Engl J Med. 1975;292:344–347. - PubMed
    1. Dobloug C, Garen T, Bitter H, Stjärne J, Stenseth G, Grøvle L, et al. Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort. Ann Rheum Dis. 2015;74:1551–1556. - PubMed

LinkOut - more resources